Understanding Pharmacovigilance Data
Pharmacovigilance data originates from clinical trial reports, real-world evidence (RWE), spontaneous adverse event reporting systems, literature searches, and public databases from regulatory bodies. This data updates frequently. Spontaneous reporting systems may add new entries daily, while regulatory databases typically update monthly or quarterly. Document structures vary, including unstructured text descriptions (e.g., clinical manifestations, medication history in adverse event reports), semi-structured tabular data (e.g., patient demographics, drug information, diagnostic codes), and structured coded data (e.g., ICD-10 diagnostic codes, MedDRA adverse reaction terms). Fields and units adhere to strict industry standards and coding systems for drug names, dosages, frequencies, durations, adverse reaction types, severity, and outcomes. For example, drug dosages are often in milligrams (mg), grams (g), or milliliters (mL), and frequencies are expressed as "tid," "bid," or "X times per week."
Constraints on "Model Integration and Configuration"
The multi-source nature, high update frequency, and mixed structured/unstructured characteristics of pharmacovigilance data impose specific requirements on model integration and configuration. First, the system needs connectors for various data sources to ensure timely data aggregation. High update frequency means the knowledge base synchronization mechanism must support incremental updates. The UPDATE_INTERVAL_SECONDS parameter requires careful setting based on data source update cycles to avoid frequent full rebuilds. Diverse document structures require the model to handle long texts, tabular data, and coded data. Unstructured text contains numerous medical terms, abbreviations, and synonyms, necessitating enhanced model understanding of domain vocabulary. This may involve custom vocabularies or specialized medical ontologies. Accurate parsing of structured fields and correct unit identification are fundamental for precise model inference. For instance, confusing dosage units can lead to severe medication error judgments. When processing this data, the model must differentiate data types and unify them into model-understandable feature vectors. This directly influences the choice of embedding model and chunk strategy.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Chunk Size) | 500–800 characters (characters) | Pharmacovigilance reports often contain detailed descriptions. This length balances contextual completeness with model processing efficiency. |
Chunk Overlap Length (Overlap Length) | 50 characters (characters) | Ensures no loss of contextual information at chunk boundaries, helping the model understand cross-paragraph relationships. |
Similarity threshold (Similarity Threshold) | 0.75–0.85 | The domain is highly specialized, requiring high similarity to ensure precision of recalled content and avoid misleading information. |
Recall count (Recall Count) | Top 8–12 entries (top 8–12) | Considering the complexity and potential interconnections of adverse event reports, recalling more items aids comprehensive evaluation. |
Rerank result count (Reranked Return Count) | Top 5 entries (top 5) | Reranking after initial recall further filters to the most relevant few items, improving final answer quality. |
Model Temperature | 0.3–0.5 | The pharmacovigilance domain demands rigor and accuracy. Lower temperature reduces the model's tendency to generate divergent or creative responses, focusing on facts. |
Common Pitfalls
- The model insufficiently understands non-standard medical terms or abbreviations in adverse event reports, leading to missing or incorrect key information. This stems from a lack of domain-specific vocabularies or pre-training data.
- After a knowledge base update, the model still outputs old or incomplete information. Query results do not match the latest data because the knowledge base synchronization mechanism is incorrectly configured or incremental updates fail.
- When users ask about drug dosages or frequencies, the model provides vague or inconsistent answers. This occurs because structured fields were not standardized during data preprocessing, leading to incorrect embedding of units or values.
Validation Steps
- Submit test questions containing typical adverse event descriptions and drug information. Verify that the model accurately identifies key entities such as drugs, symptoms, and dosages.
- Upload a new adverse event report. After the knowledge base updates, immediately query unique information from that report. Confirm the model can recall and cite the latest data.
- For drug inquiries involving multiple dosage units (e.g., mg/kg, g/day), verify the model correctly parses and provides medically appropriate recommendations, ensuring dosage unit accuracy.
- Input complex queries about drug interactions. Check if the model integrates information from multiple documents and provides logically clear, evidence-based answers.
Note: The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.